MICHAEL DALE: Open Payments
NPI 1548588262 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,049 in 45 payments from 16 companies in 2025. Trend: 2023 $2,150 · 2024 $2,758 · 2025 $2,049
Food & beverage: $2,005Education: $44
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $1,017 |
| Lilly USA, LLC | 4 | $282 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $122 |
| Phathom Pharmaceuticals, Inc. | 1 | $105 |
| Novo Nordisk Inc | 4 | $97 |
| Exact Sciences Corporation | 3 | $73 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| ABBVIE INC. | 3 | $61 |
| PFIZER INC. | 2 | $45 |
Products named: BREZTRI, AIRSUPRA, ZEPBOUND, BIJUVA, VOQUEZNA, The Cologuard Plus Collection Kit, Kerendia, VRAYLAR.
Industry payments across FL — which companies pay providers there.
